SPAST p.Pro19Ala
c.55C>G · rs372349942 · VCV1810212
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0509 | likely benign ⚠ discordant with ClinVar |
|---|---|---|
| REVEL | 0.317 | indeterminate |
| SaProt | LLR -6.75 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.2 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 1.22 | unconstrained · MANE · 52 kb · p 3.5e-06 · regional, not allelic |
| Overall | ||
| CADD | 18.14 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- SPAST
- Protein
- p.Pro19Ala
- Coding
- c.55C>G
- MANE Select
- NM_014946
- dbSNP
- rs372349942
- Type
- single nucleotide variant
- Location
- chr2:32063886 (GRCh38)
- Gene constraint
- LOEUF 0.69 · pLI 0.11 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 77.03 · 7 PDB
- Residue 19
- the 'required for interaction with rtn1' region; the 'required for midbody localization' region; the 'required for interaction with atl1' region; the 'required for nuclear localization' region; the 'disordered' region
Disease context
hereditary spastic paraplegia 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Autosomal dominant spastic paraplegia type 4 (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 1 000 000 (Portugal)
Similar variants
- SPAST p.Pro19Ser Uncertain significance ★★ ⚠ same residue
- SPAST p.Pro19= Likely benign ★ same residue
- SPAST p.Pro19Arg Uncertain significance ★ ⚠ same residue
- SPAST p.Pro19Leu Uncertain significance ★ ⚠ same residue
- SPAST c.1004+1G>C Pathogenic/Likely pathogenic ★★ same condition
- SPAST c.1004+1G>T Pathogenic ★★ same condition
- SPAST c.1004+2T>G Pathogenic ★★ same condition
- SPAST c.1098+1G>A Pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/spast-p-pro19ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown